About: Mathilde Hunault-Berger

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Mathilde Hunault-Berger Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Hunault-Berger, Mathilde (1964-..) Hunault-Berger, Mathilde (1964-..) Hunault-Berger, Mathilde (1964-..)
Life Event	http://www.idref.fr/111716195/birth
preferred label	Hunault-Berger, Mathilde (1964-..)
name	Mathilde Hunault-Berger
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
Given name	Mathilde
familyName	Hunault-Berger
has biographical i...tion (Deprecated)	En poste à l'Université d'Angers, membre du laboratoire CRCINA - eq.7 Immunité innée et immunothérapie (en 2018) Professeur des universités, praticien hospitalier dans le service des maladies du sang du CHU d'Angers en 2006
gender	female
ORCID iD	0000-0001-7777-5216
is sameAs of	Hunault-Berger, Mathilde (1964-..) Hunault-Berger, Mathilde (1964-..) Hunault-Berger, Mathilde (1964-..) Hunault-Berger, Mathilde (1964-..) Hunault-Berger, Mathilde (1964-..)
is Thesis advisor of	http://www.sudoc.fr/111714974/id http://www.sudoc.fr/255254954/id http://www.sudoc.fr/254419704/id
is Praeses of	http://www.sudoc.fr/198588631/id
is Author of	Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS. ⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids. Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous stem cell transplantation (HDT/ASCT)-induced mucositis Monitoring of asparagine depletion and anti-L-asparaginase antibodies in adult acute lymphoblastic leukemia treated in the pediatric-inspired GRAALL-2005 trial Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study https://serval.unil.ch/notice/serval:BIB_A2CACA1659FD#id Improved Survival by Adding Lomustine to Conventional Chemotherapy for Elderly Patients With AML Without Unfavorable Cytogenetics: Results of the LAM-SA 2007 FILO Trial A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome Implementation of pharmaceutical consultations in oncohematology in a teaching hospital: Over one year outcomes https://archive-ouverte.unige.ch/unige:154827#id The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients. Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression DNMT3A mutation is associated with increased age and adverse outcome in adult T-acute lymphoblastic leukemia Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich’s syndrome): frequency, clinical implication and prognosis Updated Clinical Activity of Graspa Versus Native l-Asparaginase in Combination with Cooprall Regimen in Phase 3 Randomized Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517) Diagnosis and prognosis are comforted by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01 51851 7) A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study A landscape of germ line mutations in a cohort of inherited bone marrow failure patients Epidemiology, clinical picture and long‐term outcomes of FIP1L1‐PDGFRA ‐positive myeloid neoplasm with eosinophilia: Data from 151 patients JAK inhibition for CD3− CD4+ lymphocytic-variant hypereosinophilic syndrome https://archive-ouverte.unige.ch/unige:135515#id Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study. Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence French National Retrospective Cohort of Hairy-Cell Leukemias: Risk of Second Malignancies after 10 Years of Follow-up Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience https://hal.archives-ouvertes.fr/hal-04083776#id Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care https://archive-ouverte.unige.ch/unige:99086#id Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL Concomitant CALR and LNK mutations leading to essential thrombocythemia with erythrocytosis Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial Thromboembolism Prophylaxis in Adult Patients with Acute Lymphoblastic Leukemia Treated in the GRAALL-2005 Study Severe Viral Hepatitis in a Patient with Chronic Lymphocytic Leukemia (CLL) Complicated with Autoimmune Haemolytic Anemia (AIAH), Treated with Steroids Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples. R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study https://archive-ouverte.unige.ch/unige:144872#id Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on JAK 2 V617 and MPL W515 hotspots Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Diagnosis and Treatment in a Retrospective Cohort of Thirty Patients Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517) Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study. Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: a study of the French Innovative Leukemia Organization Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation Prevention of Venous Thrombotic Events in Adult Patients with Acute Lymphoblastic Leukemia Treated in a Pediatric-Inspired Protocol - a Graall Study Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study No detection of atypical one-base deletion of CALR exon 9 with fragment analysis: A molecular trap to avoid Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software